| answer text |
<p>To help reduce regional variations, the Care Quality Commission (CQC) is increasingly
incorporating information from accreditation and peer review programmes into its assessments
of National Health Service trusts' services, including the National Cancer Peer Review
Programme. The CQC also intends to use data from the national clinical audit which
is being developed for prostate cancer. In addition, national statistics on waiting
times experienced by patients with suspected and diagnosed cancers continue to be
collected, monitored and published in order to improve equity of access to cancer
services and to contribute to an improvement in survival rates.</p><p> </p><p>The
results of the latest national Cancer Patient Experience Survey (CPES) from 2013 show
that, whilst variations between trusts still exist, the overall range of variation
for many indicators has narrowed. For example, in 2010 the proportion of patients
saying that they had been given the name of a Clinical Nurse Specialist ranged from
92% in the highest performing trust to 59% in the poorest performing trust (33 points);
by 2013 this had reduced to 97% to 76% (21 points).</p><p> </p><p>NHS Improving Quality
(NHS IQ) will be doing a suite of work across all surveys to understand what the barriers
are to implementing change and to showcase best practice where real improvements can
be demonstrated.</p><p> </p><p>NHS England is working with NHS IQ to develop better
ways of using the CPES data within the NHS in order to maximise the impact of the
survey, to be able to work with successful and struggling organisations to spread
best practice for example.</p><p> </p>
|
|
